Patents by Inventor Justine Lai

Justine Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compounds and compositions as cathepsin inhibitors
    Publication number: 20070049594
    Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: December 7, 2005
    Publication date: March 1, 2007
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Michael Graupe, John Patterson, David Aldous, Sukanthini Thurairatnam, Andreas Timm, John Link, Jiayao Li, Stephen Pickett, Frank Halley, Justine Lai
  • Compounds and compositions as cathepsin inhibitors
    Patent number: 7064123
    Abstract: The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Grant
    Filed: December 24, 2001
    Date of Patent: June 20, 2006
    Assignees: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Michael Graupe, John W. Patterson, Stephen D. Pickett, John O. Link, Jiayao Li, David Aldous, Sukanthini Thurairatnam, Andreas P. Timm, Frank Halley, Justine Lai Yeun Quai
  • Novel compounds and compositions as cathepsin inhibitors
    Publication number: 20060089357
    Abstract: The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: December 7, 2005
    Publication date: April 27, 2006
    Applicants: Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.
    Inventors: Michael Graupe, James Palmer, John Patterson, Stephen Pickett, David Aldous, Sukanthini Thurairatnam, Andreas Timm, Frank Halley, Justine Lai, John Link, Jiayao Li
  • Azaindoles
    Publication number: 20050267304
    Abstract: The invention is directed to physiologically active compounds of general formula (I):— and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
    Type: Application
    Filed: November 23, 2004
    Publication date: December 1, 2005
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Paul Cox, Tahir Majid, Justine Lai, Andrew Morley, Shelley Amendola, Stephanie Deprets, Christopher Edlin, Charles Gardner, Dorothea Kominos, Brian Pedgrift, Frank Halley, Timothy Gillespy, Michael Edwards, Francois Clerc, Conception Nemecek, Olivier Houille, Dominique Damour, Herve Bouchard, Daniel Bezard, Chantal Carrez
  • Novel compounds and compositions as cathepsin inhibitors
    Publication number: 20030105099
    Abstract: The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
    Type: Application
    Filed: June 26, 2002
    Publication date: June 5, 2003
    Inventors: Michael Graupe, James T. Palmer, John W. Patterson, Stephen D. Pickett, David J. Aldous, Sukanthini Thurairatnam, Andreas P. Timm, Frank Halley, Justine Lai, John Link, Jiayao Li